Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patientsA R Mueller, K P Platz, N Schattenfroh, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Changes in urokinase-type plasminogen activator in orthotopic liver transplantationG Himmelreich, G Dooijewaard, P Breinl, et al.
Transplantation|February 24, 2001
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantationN Rayes, D Seehofer, U Hopf, et al.
Thrombosis and Haemostasis|January 11, 1993
Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT)G Himmelreich, G Dooijewaard, P Breinl, et al.
Annals of Transplantation|June 13, 2000
Preemptive therapy in CMV-antigen positive patients after liver transplantation--a prospective trialN Rayes, H Oettle, C A Schmidt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancyW O Bechstein, G Blumhardt, H Lobeck, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 9, 2011
[Blood-borne infections and the pregnant health care worker. Risks and preventive measures]S Wicker, H F Rabenau, A E Haberl, et al.
Transplantation|February 1, 1994
Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantationG Himmelreich, M Jochum, W O Bechstein, et al.
Zeitschrift Fur Gastroenterologie|February 1, 1993
[Porphyrin-induced biliary cirrhosis in protoporphyria: indications for liver transplantation]T Steinmüller, M Frank, R Kretschmar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantationG W Haller, W O Bechstein, R Neuhaus, et al.
Pageof 23